Best Oncology Knowledge Into Practice Podcasts (2025)

1
Winning Against HFrEF 🥇💓🛠 Diagnose Early. Treat with GDMT. Follow Through 5:46

Play Pause

17h ago5:46

5:46

New Lancet Seminar on heart failure with reduced ejection fraction. 💓📘, this videocast walks listeners through the essentials of diagnosis, natriuretic peptides, imaging pathways, and the four foundational therapies shaping modern heart failure care. It's a clear, evidence-driven journey—designed to inform, clarify, and elevate bedside practice. Tu…

1
David N. Lieberman, MD, PhD - Building Clinical Confidence in the Diagnosis and Multidisciplinary Management of Rett Syndrome 23:19

7h ago23:19

23:19

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/QBS865. CME/AAPA c…

1
Bruce E. Sands, MD, MS - Fibrosis, Flares, and Forward Thinking in Inflammatory Bowel Disease Care: Unlocking the TL1A Axis 1:00:50

7h ago1:00:50

1:00:50

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/WDQ865. CME/AAPA c…

1
Philip J. Mease, MD, MACR - Taking a New Look at Psoriatic Arthritis and Its Comorbidities Through the Lens of TYK2 Inhibition 1:14:12

1d ago1:14:12

1:14:12

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/TEA8…

1
Seeing CAD Clearly 🔍❤️: Plaque, Perfusion, Prognosis 📸💓📈 6:20

1d ago6:20

6:20

🔍💓 Chronic Coronary Artery Disease: Seeing What Matters Before It Hurts Just finished reviewing the 2025 Lancet paper on contemporary non-invasive imaging for chronic CAD, and the message is striking: how we see the heart shapes how well we save it. From CT angiography that unmasks non-obstructive plaque 🖥️➡️🫀 to stress PET/CMR that maps true ische…

1
Dr RR Baliga's Philosophical Discourses: David Hume (Scotland, 1711–1776 CE) – Skepticism and Empiricism 3:25

3d ago3:25

3:25

Exploring David Hume 🧠✨ Just revisited David Hume's extraordinary contributions to modern thought — a reminder of how deeply empiricism, skepticism, and the science of human nature shape our intellectual world. His insights on causation, the limits of reason, and the power of moral sentiment continue to resonate across philosophy, psychology, econo…

1
Heart Failure Rising 📈 | Risks Rewired 🔄 | America's 35-Year Shift 🇺🇸 4:42

3d ago4:42

4:42

The U.S. heart failure landscape is transforming—and fast. 🫀📊 A new JACC analysis reveals a 35-year shift from ischemic to metabolic drivers of heart failure, with obesity, dysglycemia, and chronic kidney disease rising sharply, even as blood pressure, cholesterol, smoking, and myocardial infarction decline. 📉⚖️ These trends demand a new generation…

1
Clocks, Clues, and Clarity ⏳🔬🧠 — Decoding Organ-Specific Aging 3:20

5d ago3:20

3:20

🧬⏳ New Insights into Organ-Specific Aging! 🧠❤️🩺 Just explored a remarkable Nature Aging study showing how organ-specific proteomic clocks can forecast disease, cognitive decline, and even longevity with impressive precision. These clocks—built from >2,900 plasma proteins—reveal that the brain, kidney, and arteries age on their own timelines, each c…

1
Vaccines. Viruses. Vital Signs. 💉🦠❤️ Adult Immunizations as Cardiovascular Prevention 4:29

5d ago4:29

4:29

Respiratory vaccines are not just infection-fighters—they're cardiovascular protectors. 💉🫀 The 2025 JACC Consensus reminds us that influenza, pneumococcal, COVID-19, RSV, and zoster vaccines reduce MI, HF decompensation, hospitalizations, and death in our most vulnerable patients. As clinicians, we hold the power to translate evidence into preventi…

1
Sun, Skin, Survival 🌞🧬🛡️ – The Modern Landscape of Keratinocyte Carcinomas 3:02

6d ago3:02

3:02

The latest JAMA article on keratinocyte carcinomas 🌞—a timely reminder that BCC and cSCC remain the world's most common cancers, with more than 5.4 million cases annually in the US alone . The review highlights essential updates in epidemiology, high-risk features, prevention, and evidence-based management, especially the role of sun protection, ac…

1
Food In, Fire Out 🍽️🔥—The Leukotriene Story 🧬 4:48

7d ago4:48

4:48

🚨 Food Anaphylaxis: New Mechanisms Unveiled 🍽️🧬 A superb NEJM review highlights how cysteinyl leukotrienes act as gatekeepers in the gut—opening antigen passages, expanding mast cells, and amplifying the risk of oral anaphylaxis. The work elegantly bridges basic lipid biology with real-world food allergy challenges, and points toward new preventive…

1
Cannabis: Promise, Peril, and Practice 🌿⚖️🧭 5:07

7d ago5:07

5:07

🌿 What does the evidence really say about medical cannabis? A new JAMA review highlights a clear message: cannabis helps few conditions—and harms may outweigh benefits for many. 📉 Small benefit for nausea ⚡ Moderate benefit for select pediatric seizures 💊 Limited evidence for pain, insomnia, or psychiatric use ❤️ Risks rise with high-potency produc…

1
Dengue Blocked, Viral Load Dropped, Hope Unlocked--High-Dose Mosnodenvir Delivers 💊🚀🛡️ 3:56

8d ago3:56

3:56

Thrilled to see a major step forward in dengue prevention! 🦟💊 A new NEJM study reports that daily mosnodenvir, a first-in-class antiviral targeting the NS3–NS4B interaction, significantly reduced DENV-3 viral load and prevented infection in a controlled human challenge model. 📉🧬 It's early, but the results offer real hope for a long-awaited oral de…

1
Storms, Syncope, Survival 🌩️😵‍💫❤️ — Long QT Syndrome update 4:46

8d ago4:46

4:46

Delighted to share a concise update on the latest NEJM review of Long QT Syndrome 🫀📘 — a masterful synthesis by Schwartz & Crotti that reframes how we recognize risk, personalize therapy, and prevent sudden death in this genetically mediated disorder. The piece highlights ion-channel biology, gene-specific triggers, the impact of modifier genes, an…

1
Dr RR Baliga's Philosophical Discourses: Gottfried Wilhelm Leibniz (Germany, 1646–1716 CE) – Monadology 3:15

10d ago3:15

3:15

🧠✨ Leibniz: Harmony, Logic, and the Birth of the Digital Mind Celebrating Gottfried Wilhelm Leibniz — the mathematician-philosopher who co-created calculus, invented binary arithmetic, and envisioned a world stitched together by pre-established harmony. His Monadology reads like proto-systems theory, and his binary system is the quiet ancestor of e…

1
Genes, Environment, Development 🧬🌿🧠— A 2025 Perspective on Autism 5:15

11d ago5:15

5:15

🧬 New insights into autism: A 2025 JCI Viewpoint highlights how hundreds of genes, polygenic risk, and specific environmental factors converge during fetal brain development to shape autism likelihood. 🧠 Early biomarkers—from infant MRI and ERPs to machine-learning models using EHR data—are accelerating earlier, more tailored interventions. 🌱 Advan…

1
Numbness • Nerves • Nuance 🦶⚡🧠 — Decoding Peripheral Neuropathy 4:58

12d ago4:58

4:58

🔍 Peripheral Neuropathy: What Clinicians Should Know 🧠⚡ Peripheral neuropathy affects ~1% of adults worldwide, with diabetes accounting for more than half of all cases. The JAMA review highlights why length-dependent patterns dominate, how metabolic stress injures long axons first, and why sensory symptoms outpace motor loss. Evidence-based evaluat…

1
Stroke Risk, Stent Benefit, Surgical Uncertainty 🧠✨🔧 5:12

12d ago5:12

5:12

New NEJM insights on asymptomatic carotid stenosis 🧠🔍 The CREST-2 trials offer a landmark update: intensive medical therapy remains the cornerstone, while carotid stenting shows selective benefit when performed by expert operators. Endarterectomy, however, provides no significant advantage over modern medical management. With stricter blood-pressur…

1
UPFs, Diets, Disease: The Global Drift 🍔➡️🌍➡️⚠️ 6:26

14d ago6:26

6:26

The new Lancet Series on ultra-processed foods offers a striking insight: as UPFs rise globally, traditional whole-food diets decline—bringing nutrient imbalance, overeating, toxic exposures, and hyper-palatable formulations that quietly reshape health trajectories. 🍔➡️⚠️ Across more than 100 prospective studies and multiple trials, higher UPF inta…

1
Toby Maher, MD, MSc, PhD - Clearing the Air on Fibrosing ILDs: Pulmonologist Conversations on Timely Diagnosis and Modern Care With Antifibrotic Therapy 56:46

14d ago56:46

56:46

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/UEK865. CME/AAPA c…

1
Professor Julian Gillmore / Mathew S. Maurer, MD - Exploring New Paradigms in Transthyretin Cardiac Amyloidosis Care: Experts vs AI 54:26

14d ago54:26

54:26

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/UBF8…

1
Groceries, Guidance, Gains 🛒📞📉 — How DASH Delivery Lowers Blood Pressure 4:50

14d ago4:50

4:50

Home-delivered DASH-patterned groceries paired with dietitian counseling meaningfully lowered blood pressure and LDL cholesterol among Black adults living in food deserts 🥗📉—as demonstrated in the GoFresh randomized trial (JAMA). An accompanying editorial highlights why future "food-as-medicine" programs must prioritize underconsumed, health-promot…

1
Hemodialysis, Cardiovascular Burden, Therapeutic Hope 🩺❤️🌊 — Can Omega-3 Fatty Acids Bend the Risk Trajectory? 4:57

15d ago4:57

4:57

🩺 New insights in hemodialysis care. A major New England Journal of Medicine study reports that daily supplementation with long-chain omega-3 fatty acids (eicosapentaenoic acid and docosahexaenoic acid) led to a 43% reduction in serious cardiovascular events among adults receiving maintenance hemodialysis. 🐟💙 In a population where traditional cardi…

1
💊 Oral, Potent, Proven — Enlicitide Redefines LDL Control 7:03

16d ago7:03

7:03

🚀 A milestone moment in lipid therapeutics! The new JAMA trial on the oral PCSK9 inhibitor Enlicitide reports a ~60% reduction in LDL-C, with parallel decreases in ApoB and Lp(a)—all on top of maximally tolerated statin therapy. For individuals with heterozygous familial hypercholesterolemia (HeFH)—where reaching LDL targets remains a persistent ch…

1
One Cup of Coffee. Less Atrial Fib/Flutter. More Life ☕🌀➡️💛 3:07

17d ago3:07

3:07

☕ DECAF Trial insight! A new JAMA study shows that daily caffeinated coffee may lower recurrence of atrial fibrillation compared with abstinence. Patients drinking ~1 cup/day had 47% recurrence vs 64% with abstinence (HR 0.61, p=0.01) 📉💓 No major safety concerns—challenging long-held beliefs that coffee is proarrhythmic. 💡Takeaway: For many patient…

1
Improving CAR-T Access 32:54

18d ago32:54

32:54

Dr. Chino talks with Dr. Navneet Majhail and patient advocate Laurie Adami about CAR-T therapy, an advance cancer treatment that biologically engineers a patient's own T-cells to recognize and kill cancer cells. This discussion will be based off the JCO OP article, "Outpatient Administration of Chimeric Antigen Receptor T-Cell Therapy Using Remote …

1
Beyond the Culprit: Complete Revascularisation • Fewer Deaths • Better Futures 💖🩺✨ 4:42

18d ago4:42

4:42

🚨 New insights from The Lancet 🚨 A major individual-patient-data meta-analysis (6 RCTs, 8,836 patients) shows that complete revascularisation in acute myocardial infarction significantly reduces cardiovascular death, all-cause mortality, and recurrent MI. 💓📉 Benefits were consistent across age, sex, STEMI/NSTEMI, and lesion characteristics — streng…

1
Olezarsen Cuts Triglycerides. Calms Pancreas. Changes Outcomes. 🧬🔥🛡️ 2:31

20d ago2:31

2:31

🧬 New NEJM data on Olezarsen! In patients with severe hypertriglyceridemia, monthly RNA-targeted therapy delivered major triglyceride reductions (−62% to −72%) and a significant drop in acute pancreatitis risk (rate ratio 0.15). ✨ Improvements extended to ApoC-III, remnant cholesterol, and non-HDL cholesterol, with consistent benefits across both C…

1
MI Aftercare: The Beat Goes On—With or Without Beta-Blockers 🥁➡️❤️ 3:16

20d ago3:16

3:16

📘 New Evidence from NEJM In a large meta-analysis of 17,801 patients with preserved LVEF after MI, beta-blockers did not reduce death, recurrent MI, or heart failure. Event rates were low, and outcomes were similar with or without therapy. 🫀📊 This clarifies practice for a growing post-MI population with LVEF ≥50%—precision matters more than traditi…

1
Malaz Boustani, MD, MPH, Charles Vega, MD, FAAFP - Brain Health Morning Report: Adapting Primary Care Practice and Workflows to Meet the Needs of an Aging Population 1:01:46

21d ago1:01:46

1:01:46

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/APA/IPCE information, and to apply for credit, please visit us at PeerView.…

1
Jiwon Oh, MD, PhD, FRCPC - Quiet Progression, Loud Impact in MS: Expert Insights on the Role of BTK Inhibitors Beyond Relapse 34:15

21d ago34:15

34:15

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/CXV865. CME/AAPA c…

1
Prof. Dr. med. Alexander Drzezga - Nuclear Medicine for Alzheimer’s Disease in the Hot Seat: Case Conference on Advancing Early Diagnosis With PET Imaging and Biomarkers 1:09:59

21d ago1:09:59

1:09:59

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/EBAC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/APF865. …

1
NOAC Monotherapy Wins in Afib with Drug Eluting Stents: Safer, Stronger, Smarter ⚖️🔥🧠 3:02

21d ago3:02

3:02

📢 ADAPT AF-DES Trial — A Safer Path Forward! In patients with atrial fibrillation beyond 1 year after drug-eluting stent implantation, NOAC monotherapy delivered striking benefits over combination therapy. ✅ Lower net adverse clinical events ✅ Marked reduction in major/CRNM bleeding ✅ Similar ischemic protection A beautifully simple strategy with m…

1
OCEAN Trial: Ablate Afib. Assess. Anticoagulate? 🌊 3:53

22d ago3:53

3:53

🌊 OCEAN Trial offers fresh insight into antithrombotic therapy after successful AF ablation. In 1284 patients followed for 3 years, event rates were remarkably low 🌟. Rivaroxaban did not show superiority over aspirin for preventing stroke, systemic embolism, or covert embolic events, while bleeding risk was higher with anticoagulation. 🧠 96% had no…

1
Dr RR Baliga's Philosophical Discourses: John Locke (England, 1632–1704 CE) – Empiricism 5:27

24d ago5:27

5:27

🧠 John Locke: Experience • Liberty • Toleration Born a physician-philosopher, Locke championed empiricism — the idea that knowledge begins with experience, not dogma. His tabula rasa shaped modern psychology, while his Two Treatises of Government defined rights, consent, and freedom that echo through modern democracies. For clinicians, his legacy r…

1
Evolocumab in Primary Prevention." 🧬🛡️🎯 LDL: Down 55%. CV Events: Down 25%. 4:52

24d ago4:52

4:52

🚀 VESALIUS-CV delivers powerful evidence: in high-risk patients without prior MI or stroke, evolocumab significantly reduced 3-point MACE by 25% and 4-point MACE by 19%, with LDL-C lowered to a median of 45 mg/dL. 💡 These results expand the horizon of prevention, showing that deep LDL reduction is both safe and effective in averting first cardiovas…

1
Capillary Clues, Clinical Wins: Targeting Capillary Refill Time in Acute Septic Shock 🔍🩸✅ 4:48

26d ago4:48

4:48

🫀 Septic Shock, Refined at the Fingertips ⏱️ A powerful new JAMA (2025) trial brings us one step closer to truly personalized resuscitation. The ANDROMEDA-SHOCK-2 study shows that targeting capillary refill time (CRT) — a simple bedside sign — can shorten time on organ support vs usual care, without increasing mortality. Key insight: Sometimes the …

1
SOFA-2 ICU Unveiled 🧠⚙️📊 3 Million Patients, 9 Nations, One New Standard 4:38

27d ago4:38

4:38

🚨 SOFA-2 arrives — a thoughtful evolution in critical care scoring 🧠🫁🫀 After nearly 30 years, the SOFA score has been modernized using data from >3.3 million ICU patients across 9 countries. The updated SOFA-2 incorporates contemporary respiratory and cardiovascular supports (HFNC, NIPPV, vasopressors, ECMO) and refines thresholds while preserving …

1
SOFA-2 Unveiled 🧠⚙️🌍-📊🩺🚨 — Critical Care Enters a New Era 4:15

28d ago4:15

4:15

SOFA-2 is here — a major advance in assessing organ dysfunction in critical illness 🧠🫁❤️ Three decades after the original SOFA score, this updated framework reflects modern ICU practice — integrating contemporary organ support (ventilation, vasopressors, RRT), delirium recognition, and global feasibility across resource settings 🌍📊 Validated in 3.3…

1
💔 Peripartum Cardiomyopathy: Detect Early • Treat Aggressively • Protect Mothers 5:01

28d ago5:01

5:01

💔 Peripartum Cardiomyopathy: When a Mother's Heart Fights for Two Peripartum cardiomyopathy is a leading yet often missed cause of maternal morbidity and mortality—striking late in pregnancy or months postpartum. Early suspicion, timely echo, and guideline-directed therapy save lives. 🩺 🧠 Bromocriptine, careful anticoagulation, and multidisciplinar…

1
Rethinking "default arterial lines" in the ICU 🧠🚑 5:00

29d ago5:00

5:00

Rethinking "default lines" in the ICU 🧠🚑 A landmark NEJM trial shows that in patients with shock, deferring arterial catheterization and using automated cuff monitoring was noninferior for 28-day mortality — and reduced catheter-related complications. A gentle reminder: not every sick patient needs a needle to be well cared for. Precision isn't onl…

1
Light Pollution, Circadian Disruption, Cardiac Vulnerability 🌃🕰️🫀 4:19

29d ago4:19

4:19

🌙 Bright Nights, Higher Heart Risk ❤️‍🩹 New findings in JAMA Network Open highlight that greater exposure to artificial light at night is associated with significantly increased risks of coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, and stroke — independent of sleep duration, lifestyle factors, and genetics. 💡 …

1
Rethinking Immune Aging: It Starts Sooner Than We Think 💡🩸 4:23

30d ago4:23

4:23

The immune clock starts earlier than we think ⏳🧬 A landmark Nature study shows that immune aging begins quietly in midlife — decades before clinical frailty. Using >16M single-cell profiles and longitudinal vaccine responses, researchers found: • Stable, early transcriptional drift in naïve & memory T cells • A subtle TH2 shift that may weaken anti…

1
Seven Years Later: TAVR Didn't Blink 😎🫀 3:28

1M ago3:28

3:28

🫀 TAVR or SAVR? The 7-Year Truth New 7-year results from the PARTNER-3 trial (NEJM) show that in low-risk patients with severe symptomatic aortic stenosis, TAVR holds pace with surgery — delivering comparable survival, stroke rates, rehospitalization, valve durability, and quality-of-life outcomes. 🔎 Highlights • Composite events: 34.6% (TAVR) vs 3…

1
Dr RR Baliga's Philosophical Discourses: Baruch Spinoza (Netherlands, 1632–1677 CE) – Ethics 6:00

1M ago6:00

6:00

🌿 Spinoza: Reason, Nature, Freedom Today's deck explores Baruch Spinoza — the quietly revolutionary Dutch philosopher who shaped rationalism, modern biblical criticism, and secular democracy. He saw God = Nature, championed intellectual freedom, and argued that understanding our emotions transforms them — not far from cognitive-behavioral ideas we …

1
New Mitral Frontier 🚪🫀🚶‍♂️ TMVR Opens a Third Pathway 5:14

1M ago5:14

5:14

A new era for complex mitral regurgitation. The ENCIRCLE pivotal trial in The Lancet reports that fully percutaneous, transfemoral, transseptal TMVR (SAPIEN M3) achieved durable MR reduction (≈96% ≤1+ at 1 year), low early mortality, and meaningful improvement in symptoms and quality of life for patients unsuitable for surgery or TEER. A third path…

1
Immune Fountain of Youth? Mesenchymal Magic 💧✨ 3:44

1M ago3:44

3:44

🧬 Can we rejuvenate the aging immune system? A remarkable Nature Biotechnology study shows that a rare population of periostin-positive mesenchymal niche cells can rebuild the adult thymus, recruit new T-cell progenitors, and restore immune responses after injury. By harnessing CCL19-expressing stromal support, the authors demonstrate a path toward…

1
Cancer, Cure, Cardio-Care 🔬✅🫀 Not Every Survivor Needs a Cardiologist — But Every Heart Needs Attention 4:53

1M ago4:53

4:53

🩺🎗️ Cardio-Oncology Insight: Not Every Breast Cancer Survivor Needs a Cardiologist As breast cancer survivorship grows, understanding who truly benefits from long-term cardiac follow-up becomes essential. An important editorial in JAMA Oncology underscores a key principle: risk-stratified care, not reflex surveillance. 👩‍⚕️🔍 Age and traditional car…

1
Urolithin A: The Immune Youth Serum? ✨🧫🧓➡️🧑‍⚕️ 3:41

1M ago3:41

3:41

🧬 Can we rejuvenate the aging immune system? A new Nature Aging trial suggests we might be closer than we thought. In 50 healthy adults aged 45–70, urolithin A—a mitophagy activator—improved immune fitness over just 28 days: ✅ ↑ naïve CD8⁺ T cells ✅ ↓ exhaustion markers (TOX) ✅ ↑ mitochondrial biogenesis (PGC-1α) ✅ ↑ fatty-acid oxidation capacity ✅…

1
Short DAPT Wins, Ultra-Short Fails 🚫1️⃣✅3️⃣ Stratified Strategy From HOST-BR 3:49

1M ago3:49

3:49

🫀 Personalizing DAPT: When "One Size Fits All" Fails 🕊️💊 The HOST-BR trial in The Lancet offers an important clinical lesson: Bleeding risk should guide antiplatelet duration after PCI — not habit, not inertia. 🔍 Key insight In ARC-HBR patients, 1-month DAPT was not non-inferior to 3 months In non-HBR patients, 3-month DAPT was non-inferior to 12 m…